Getty ImagesShares of . gained 1.1 per cent to Rs 446.3 in Tuesday's session as of 10:15AM (IST) even as the equity benchmark Sensex traded 407.02 points lower at 60340.29.
Earlier in the day, the stock witnessed a gap up start to the session. The stock quoted a 52-week high price of Rs 742.25 and a 52-week low of Rs 429.3 on NSE. Around 4155 shares changed hands on the counter till 10:15AM (IST).
The stock opened at Rs 442.0 and has touched an intraday high and low of Rs 447.05 and Rs 442.0 during the session so far. The counter quoted a price-to-earnings (PE) ratio of 12.4, earnings per share (EPS) of Rs 36.03 and price to book value (PB) of 1.59, while the return on equity (ROE) stood at Rs 10.77.
Promoter/ FII Holding
The promoters held 51.83 per cent stake in the company as of January 10, while FII and MF ownerships stood at 22.43 per cent and 8.96 per cent, respectively.
Key Financials
With a market capitalisation of Rs 26170.95 crore, the company operates in the Pharma - Indian industry. For the quarter ended 30-Sep-2022, the company reported consolidated sales of Rs 5796.56 crore, down 7.65 per cent from the previous quarter?s Rs 6276.54 crore and down 4.01 per cent from the same quarter a year ago. The company reported net profit of Rs 409.45 crore for the latest quarter, down 41.25 per cent from the corresponding quarter last year.
Technical Indicators
The relative strength index (RSI) of the stock stands at 46.77. The RSI oscillates between zero and 100. Traditionally, it is considered overbought condition when the RSI value is above 70 and oversold condition when it is below 30. Analysts say the RSI indicator should not be seen in isolation, as it may not be sufficient to take a trading call, just the way a fundamental analyst cannot give a "buy" or "sell" recommendation using a single valuation ratio.
Earlier in the day, the stock witnessed a gap up start to the session. The stock quoted a 52-week high price of Rs 742.25 and a 52-week low of Rs 429.3 on NSE. Around 4155 shares changed hands on the counter till 10:15AM (IST).
The stock opened at Rs 442.0 and has touched an intraday high and low of Rs 447.05 and Rs 442.0 during the session so far. The counter quoted a price-to-earnings (PE) ratio of 12.4, earnings per share (EPS) of Rs 36.03 and price to book value (PB) of 1.59, while the return on equity (ROE) stood at Rs 10.77.
Promoter/ FII Holding
The promoters held 51.83 per cent stake in the company as of January 10, while FII and MF ownerships stood at 22.43 per cent and 8.96 per cent, respectively.
Key Financials
With a market capitalisation of Rs 26170.95 crore, the company operates in the Pharma - Indian industry. For the quarter ended 30-Sep-2022, the company reported consolidated sales of Rs 5796.56 crore, down 7.65 per cent from the previous quarter?s Rs 6276.54 crore and down 4.01 per cent from the same quarter a year ago. The company reported net profit of Rs 409.45 crore for the latest quarter, down 41.25 per cent from the corresponding quarter last year.
Technical Indicators
The relative strength index (RSI) of the stock stands at 46.77. The RSI oscillates between zero and 100. Traditionally, it is considered overbought condition when the RSI value is above 70 and oversold condition when it is below 30. Analysts say the RSI indicator should not be seen in isolation, as it may not be sufficient to take a trading call, just the way a fundamental analyst cannot give a "buy" or "sell" recommendation using a single valuation ratio.
Read More News on
(What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)
...moreDownload The Economic Times News App to get Daily Market Updates & Live Business News.